Literature DB >> 9036968

A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes.

D Plaksin1, K Polakova, P McPhie, D H Margulies.   

Abstract

We have expressed in bacteria a single-chain T cell receptor (scTCR) with specificity for an HIV gp120-derived peptide bound to the murine MHC-I molecule, H-2Dd. This scTCR consists of V alpha covalently linked to the VbetaCbeta domains that was solubilized, refolded, and purified in high yield. Specific binding of the scTCR to MHC/peptide complexes was demonstrated by surface plasmon resonance, with a Kd of 2 to 8 x 10(-6) M. This scTCR specifically inhibited T cell activation, and stained cell surface MHC/peptide complexes as measured by cytofluorimetry. The preservation of binding specificity by such a three-domain scTCR suggests that this structure is sufficient for specific MHC/peptide recognition and that this strategy will be of general use as applied to other TCR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036968

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.

Authors:  David H Aggen; Adam S Chervin; Francis K Insaidoo; Kurt H Piepenbrink; Brian M Baker; David M Kranz
Journal:  Protein Eng Des Sel       Date:  2010-12-14       Impact factor: 1.650

Review 2.  Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.

Authors:  J M Boulter; B K Jakobsen
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Molecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution.

Authors:  Yohko Nakagawa; Hiroto Kikuchi; Hidemi Takahashi
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

4.  Estimation of low frequency antigen-presenting cells with a novel RELISPOT assay.

Authors:  Amiran K Dzutsev; Igor M Belyakov; Dmitry V Isakov; Susan J Gagnon; David H Margulies; Jay A Berzofsky
Journal:  J Immunol Methods       Date:  2008-02-08       Impact factor: 2.303

5.  Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.

Authors:  G Zhong; C Reis e Sousa; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Paired cloning of the T cell receptor alpha and beta genes from a single T cell without the establishment of a T cell clone.

Authors:  M Kurokawa; J Tong; T Matsui; K Masuko-Hongo; T Yabe; K Nishioka; K Yamamoto; T Kato
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

7.  Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA.

Authors:  Kristin S Gunnarsen; Elin Lunde; Per E Kristiansen; Bjarne Bogen; Inger Sandlie; Geir Å Løset
Journal:  BMC Biotechnol       Date:  2010-02-03       Impact factor: 2.563

8.  Selection of functional T cell receptor mutants from a yeast surface-display library.

Authors:  M C Kieke; E V Shusta; E T Boder; L Teyton; K D Wittrup; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  An allosteric site in the T-cell receptor Cβ domain plays a critical signalling role.

Authors:  Kannan Natarajan; Andrew C McShan; Jiansheng Jiang; Vlad K Kumirov; Rui Wang; Huaying Zhao; Peter Schuck; Mulualem E Tilahun; Lisa F Boyd; Jinfa Ying; Ad Bax; David H Margulies; Nikolaos G Sgourakis
Journal:  Nat Commun       Date:  2017-05-16       Impact factor: 14.919

10.  T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment.

Authors:  Keith R Miller; Akiko Koide; Brenda Leung; Jonathan Fitzsimmons; Bryan Yoder; Hong Yuan; Michael Jay; Sachdev S Sidhu; Shohei Koide; Edward J Collins
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.